{
    "id": "correct_subsidiary_00045_0",
    "rank": 86,
    "data": {
        "url": "https://www.medchemexpress.com/Rapamycin.html",
        "read_more_link": "",
        "language": "en",
        "title": "Rapamycin (Sirolimus)",
        "top_image": "https://file.medchemexpress.com/product_pic/hy-10219.gif",
        "meta_img": "https://file.medchemexpress.com/product_pic/hy-10219.gif",
        "images": [
            "https://file.medchemexpress.com/mce-com-email/singlePage/close-img.png",
            "https://www.medchemexpress.com/new/images/web/mceLogo.png",
            "https://file.medchemexpress.com/mce-com-email/2023/usa-top-gif.gif",
            "https://file.medchemexpress.com/mce-com-email/2023/exhibitionAdvertisement.gif",
            "https://file.medchemexpress.com/mce-com-email/2023/europe-activity.gif",
            "https://file.medchemexpress.com/mce-com-email/2023/hk-activity.gif",
            "https://file.medchemexpress.com/mce-com-email/2024/eu-ciation-gif.gif",
            "https://file.medchemexpress.com/mce-com-email/2024/icon-solubulity.svg",
            "https://file.medchemexpress.com/mce-com-email/2024/icon-calculator.svg",
            "https://file.medchemexpress.com/mce-com-email/2024/icon-mouse.svg",
            "https://file.medchemexpress.com/new/images/web/authorization.jpg",
            "https://file.medchemexpress.com/product_pic/hy-10219.gif",
            "https://file.medchemexpress.cn/new/images/web/pro-prev-arrow.svg",
            "https://file.medchemexpress.cn/new/images/web/pro-next-arrow.svg",
            "https://file.medchemexpress.com/new/images/web/top-publications-picture-en.png",
            "https://file.medchemexpress.com/literature_picture/33400-1.gif",
            "https://file.medchemexpress.com/literature_picture/32870-1.gif",
            "https://file.medchemexpress.com/literature_picture/33400-1.gif",
            "https://file.medchemexpress.com/literature_picture/32870-1.gif",
            "https://file.medchemexpress.com/literature_picture/33568-2.gif",
            "https://file.medchemexpress.com/literature_picture/11340-1.gif",
            "https://file.medchemexpress.com/literature_picture/3970-1.gif",
            "https://file.medchemexpress.com/literature_picture/4601-4.gif",
            "https://file.medchemexpress.com/literature_picture/3455-1.gif",
            "https://file.medchemexpress.com/literature_picture/3448-2.gif",
            "https://file.medchemexpress.com/literature_picture/2228-4.gif",
            "https://file.medchemexpress.com/literature_picture/6252-3.gif",
            "https://file.medchemexpress.com/literature_picture/6252-1.gif",
            "https://file.medchemexpress.com/literature_picture/3509-1.gif",
            "https://file.medchemexpress.com/literature_picture/5077-1.gif",
            "https://file.medchemexpress.com/literature_picture/5077-2.gif",
            "https://file.medchemexpress.com/literature_picture/3753-1.gif",
            "https://file.medchemexpress.com/literature_picture/3704-2.gif",
            "https://file.medchemexpress.com/literature_picture/4223-3.gif",
            "https://file.medchemexpress.com/literature_picture/4223-2.gif",
            "https://file.medchemexpress.com/literature_picture/1593-1.gif",
            "https://file.medchemexpress.com/literature_picture/1793-1.gif",
            "https://file.medchemexpress.com/literature_picture/2089-1.gif",
            "https://file.medchemexpress.com/literature_picture/1561-1.gif",
            "https://file.medchemexpress.com/literature_picture/483-1.gif",
            "https://file.medchemexpress.com/literature_picture/51-2.gif",
            "https://cdn.bioz.com/assets/favicon.png",
            "https://file.medchemexpress.com/new/images/web/ckb-unchecked.png",
            "https://file.medchemexpress.com/new/images/web/ckb-unchecked.png",
            "https://file.medchemexpress.com/new/images/web/magic-cece-mce-en-@2x.png",
            "https://file.medchemexpress.com/mce-com-email/2022/calendar-tc.jpg",
            "https://file.medchemexpress.com/mce-com-email/singlePage/calendar-campaign-pop.png",
            "https://googleads.g.doubleclick.net/pagead/viewthroughconversion/969428982/?value=0&guid=ON&script=0",
            "https://googleads.g.doubleclick.net/pagead/viewthroughconversion/1000346259/?value=0&guid=ON&script=0"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Rapamycin | 53123-88-9 | Sirolimus |  AY-22989 | AY22989 | AY 22989 | AY-22989 | mTOR | FKBP | Fungal | Autophagy | Endogenous Metabolite | Antibiotic | Bacterial | Mammalian target of Rapamycin | FK506-binding protein | HEK293 | FKBP12 | mTORC1 | autophagy | immunosuppressant | Inhibitor | inhibitor | inhibit"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Rapamycin (Sirolimus; AY 22989) is a potent and specific mTOR inhibitor with an IC50 of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1. Rapamycin is an autophagy activator, an immunosuppressant. - Mechanism of Action & Protocol.",
        "meta_lang": "",
        "meta_favicon": "/favicon.ico",
        "meta_site_name": "MedchemExpress.com",
        "canonical_link": "https://www.medchemexpress.com/Rapamycin.html",
        "text": "Solvent & Solubility\n\nIn Vitro:\n\nDMSO : 125 mg/mL (136.74 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)\n\nEthanol : 50 mg/mL (54.69 mM; Need ultrasonic)\n\nPreparing\n\nStock Solutions\n\nConcentration Solvent Mass 1 mg 5 mg 10 mg\n\n1 mM 1.0939 mL 5.4694 mL 10.9389 mL 5 mM 0.2188 mL 1.0939 mL 2.1878 mL 10 mM 0.1094 mL 0.5469 mL 1.0939 mL\n\nView the Complete Stock Solution Preparation Table\n\n* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.\n\nStorage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.\n\nMolarity Calculator\n\nDilution Calculator\n\nMass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)\n\nMass\n\n=\n\nConcentration\n\n×\n\nVolume\n\n×\n\nMolecular Weight *\n\nConcentration (start) × Volume (start) = Concentration (final) × Volume (final)\n\nThis equation is commonly abbreviated as: C1V1 = C2V2\n\nConcentration (start)\n\nC1\n\n×\n\nVolume (start)\n\nV1\n\n=\n\nConcentration (final)\n\nC2\n\n×\n\nVolume (final)\n\nV2\n\nIn Vivo:\n\nSelect the appropriate dissolution method based on your experimental animal and administration route.\n\nFor the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:\n\nTo ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.\n\nThe percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.\n\nProtocol 1\n\nAdd each solvent one by one: 10% EtOH 40% PEG300 5% Tween-80 45% Saline\n\nSolubility: ≥ 2.5 mg/mL (2.73 mM); Suspended solution\n\nThis protocol yields a suspended solution of ≥ 2.5 mg/mL (saturation unknown). Suspended solution can be used for oral and intraperitoneal injection.\n\nTaking 1 mL working solution as an example, add 100 μL EtOH stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.\n\nPreparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.\n\nProtocol 2\n\nAdd each solvent one by one: 10% EtOH 90% (20% SBE-β-CD in Saline)\n\nSolubility: 2.5 mg/mL (2.73 mM); Suspended solution; Need ultrasonic\n\nThis protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.\n\nTaking 1 mL working solution as an example, add 100 μL EtOH stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.\n\nPreparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.\n\nProtocol 3\n\nAdd each solvent one by one: 10% EtOH 90% Corn Oil\n\nSolubility: ≥ 2.5 mg/mL (2.73 mM); Suspended solution\n\nThis protocol yields a suspended solution of ≥ 2.5 mg/mL (saturation unknown). Suspended solution can be used for oral and intraperitoneal injection.\n\nTaking 1 mL working solution as an example, add 100 μL EtOH stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.\n\nProtocol 4\n\nAdd each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline\n\nSolubility: ≥ 2.08 mg/mL (2.28 mM); Clear solution\n\nThis protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).\n\nTaking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.\n\nPreparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.\n\nProtocol 5\n\nAdd each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)\n\nSolubility: 2.08 mg/mL (2.28 mM); Suspended solution; Need ultrasonic\n\nThis protocol yields a suspended solution of 2.08 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.\n\nTaking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.\n\nPreparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.\n\nProtocol 6\n\nAdd each solvent one by one: 10% DMSO 90% Corn Oil\n\nSolubility: ≥ 2.08 mg/mL (2.28 mM); Clear solution\n\nThis protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.\n\nTaking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL Corn oil, and mix evenly.\n\nProtocol 7\n\nAdd each solvent one by one: 0.5% CMC-Na/1% Tween-80 in Saline water\n\nSolubility: 1.98 mg/mL (2.17 mM); Suspended solution; Need ultrasonic\n\nIn Vivo Dissolution Calculator\n\nPlease enter the basic information of animal experiments:\n\nDosage\n\nmg/kg\n\nAnimal weight\n\n(per animal)\n\ng\n\nDosing volume\n\n(per animal)\n\nμL\n\nNumber of animals\n\nRecommended: Prepare an additional quantity of animals to account for potential losses during experiments.\n\nPlease enter your animal formula composition:\n\n%\n\nDMSO +\n\n%\n\n+\n\n%\n\nTween-80 +\n\n%\n\nSaline\n\nRecommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.\n\nThe co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).\n\nCalculation results:\n\nWorking solution concentration: mg/mL\n\nMethod for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).\n\nThe concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).\n\nTel: 609-228-6898\n\nE-mail: [email protected]\n\nTechnical Support: [email protected]\n\nMethod for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.\n\nDissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution\n\nIf the continuous dosing period exceeds half a month, please choose this protocol carefully.\n\nPlease ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution."
    }
}